One year ago, the bank laid out a path toward "normalized" annual earnings of $27.5B, a number that could be tough to reach this year given continued pressure on interest margins, but Jefferies' Ken Usdin believes JPMorgan (JPM +0.1%) will deliver "with some help from incremental cost control and other new growth initiatives." This implies EPS of $6.50-$7, but don't forget buybacks which could drive the figure closer to $7.50, says Usdin.
He rates the stock a Buy with $66 price target.
Credit Suisse's Moshe Orenbuch says the net income target could rise as high as $29B "as legal mortgage expenses normalize and JPM realizes benefits of its growth initiatives." Orenbuch is modeling for $2.5B in litigation expenses in 2014, but reserves of (an estimated) $8B provide plenty of cover.
He rates the stock a Buy with $70 price target.